Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
07/18/2025 | CALL | $5.00 | 2,692 | +480 | +21.70% |
06/20/2025 | CALL | $2.50 | 837 | +444 | +112.98% |
07/18/2025 | CALL | $2.50 | 1,983 | +150 | +8.18% |
01/16/2026 | CALL | $2.00 | 547 | +132 | +31.81% |
01/16/2026 | CALL | $5.00 | 2,906 | +77 | +2.72% |
01/16/2026 | PUT | $2.50 | 495 | +50 | +11.24% |
06/20/2025 | CALL | $7.50 | 1 | 0 | |
06/20/2025 | PUT | $2.50 | 66 | 0 | |
06/20/2025 | PUT | $5.00 | 0 | 0 | |
06/20/2025 | PUT | $7.50 | 0 | 0 | |
07/18/2025 | PUT | $7.50 | 0 | -1 | -100.00% |
01/16/2026 | PUT | $1.50 | 146 | -2 | -1.35% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 2.27% | 4.34M | 27.06M |
Vanguard Total Stock Market Index Fund | 1.55% | 2.97M | 18.49M |
Vanguard U.S. Growth Fund | 1.28% | 2.46M | 15.3M |
Vanguard Small-Cap Index Fund | 1.28% | 2.45M | 15.29M |
iShares Russell 2000 ETF | 1.02% | 1.95M | 12.15M |
Price (T.Rowe) New Horizons Fund | 0.89% | 1.71M | 10.64M |
Price (T.Rowe) Health Sciences Fund | 0.84% | 1.61M | 10.02M |
Vanguard Small-Cap Growth Index Fund | 0.74% | 1.42M | 8.82M |
Vanguard Extended Market Index Fund | 0.63% | 1.2M | 7.46M |
iShares Russell 2000 Value ETF | 0.46% | 886.99k | 5.53M |
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm
05/19 10:22 am
Benzinga
Read moreINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
05/14 02:50 pm
GlobeNewswire Inc.
Read moreSANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm
05/12 09:50 am
Benzinga
Read moreFaruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - SANA
05/11 09:40 am
GlobeNewswire Inc.
Read moreSANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
05/04 04:00 pm
GlobeNewswire Inc.
Read moreSANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm
04/29 09:30 am
Benzinga
Read moreINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
04/29 08:00 am
GlobeNewswire Inc.
Read moreEU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that enCore Energy Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
04/27 04:00 pm
GlobeNewswire Inc.
Read moreSANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
04/27 04:00 pm
GlobeNewswire Inc.
Read moreROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
04/27 01:57 pm
GlobeNewswire Inc.
Read moreINVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
04/26 10:42 am
GlobeNewswire Inc.
Read moreSANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm
04/24 10:32 am
Benzinga
Read moreINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
04/21 11:00 am
GlobeNewswire Inc.
Read moreDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
04/20 08:32 am
GlobeNewswire Inc.
Read moreROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATNM
04/18 01:58 pm
GlobeNewswire Inc.
Read moreROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
04/18 01:38 pm
GlobeNewswire Inc.
Read moreROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
04/12 01:20 pm
GlobeNewswire Inc.
Read moreROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
04/05 10:35 pm
GlobeNewswire Inc.
Read moreROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
04/02 09:09 pm
GlobeNewswire Inc.
Read moreContact The Gross Law Firm by May 20, 2025 Deadline to Join Class Action Against Sana Biotechnology, Inc. (SANA)
03/31 01:01 pm
GlobeNewswire Inc.
Read moreSANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
03/30 04:00 pm
GlobeNewswire Inc.
Read moreCAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain
03/05 02:00 pm
GlobeNewswire Inc.
Read moreSana Biotechnology to Present at May and June 2024 Investor Conferences
05/06 04:05 pm
GlobeNewswire Inc.
Read more4 Stocks to Keep a Tab on for Amazing Earnings Acceleration
05/03 07:25 am
Zacks Investment Research
Read moreTesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
03/04 11:40 am
Benzinga
Read moreCooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
03/01 12:18 pm
Benzinga
Read moreSana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
02/29 05:05 pm
GlobeNewswire Inc.
Read moreSana Biotechnology to Present at the Cowen 44th Annual Health Care Conference
02/28 05:05 pm
GlobeNewswire Inc.
Read moreSana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP
02/13 05:05 pm
GlobeNewswire Inc.
Read morePayPal Reports Q4 Results, Joins Rapid7, GoPro And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
02/08 05:49 am
Benzinga
Read moreSana Biotechnology Announces Pricing of Upsized Public Offering
02/08 02:22 am
GlobeNewswire Inc.
Read moreSana Biotechnology Announces Proposed Public Offering of Common Stock
02/07 05:01 pm
GlobeNewswire Inc.
Read moreAre You Looking for a Top Momentum Pick? Why Sana Biotechnology (SANA) is a Great Choice
01/18 01:00 pm
Zacks Investment Research
Read moreSana Bio (SANA) Stock Rallies 105% in 3 Months: Here's Why
01/18 11:24 am
Zacks Investment Research
Read moreAspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday
01/11 11:32 am
Benzinga
Read moreSana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC262, a Hypoimmune-modified, CD22-directed Allogeneic CAR T Therapy, for Patients with Relapsed or Refractory B-cell Malignancies
01/05 10:00 am
GlobeNewswire Inc.
Read moreSana Biotechnology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
01/03 05:05 pm
GlobeNewswire Inc.
Read moreSana Biotechnology Highlights Preclinical Data Supporting Tumor Control and Immune Evasion Capabilities of Hypoimmune-Modified Allogeneic CAR T Cells in Presentations at the American Society of Hematology Annual Meeting
12/11 10:00 am
GlobeNewswire Inc.
Read moreSana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune Detection in Presence of Intact Immune System
12/01 05:05 pm
GlobeNewswire Inc.
Read moreSana Biotechnology Reports Third Quarter 2023 Financial Results and Business Updates
11/08 05:05 pm
GlobeNewswire Inc.
Read moreSana Biotechnology Announces Five Presentations at the 65th American Society of Hematology Annual Meeting
11/02 09:05 am
GlobeNewswire Inc.
Read moreBenzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
09/25 11:00 am
Benzinga
Read more